Related Experiment Video
Updated: Sep 10, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
Published on: September 4, 2017
Estimation of benchmark dose ratio distributions for subchronic-to-chronic extrapolation using meta-analysis
Todd Blessinger1, John Fox2, Jeffry Dean3
1Center for Public Health and Environmental Assessment (CPHEA), United States Environmental Protection Agency (US EPA), Washington, DC 20460, United States.
The International Programme on Chemical Safety (IPCS) developed a probabilistic framework and software (APROBA) for chemical safety reference values. New data suggest APROBA may underestimate uncertainty for some toxicological predictions.
Area of Science:
- Environmental Health
- Toxicology
- Risk Assessment
Background:
- The International Programme on Chemical Safety (IPCS) established a probabilistic framework and the Approximate Probabilistic Analysis (APROBA) software for deriving chemical reference values.
- This framework estimates uncertainty and variability, including extrapolation from subchronic to chronic toxicity data, using benchmark doses (BMD).
Purpose of the Study:
- To re-evaluate the subchronic-to-chronic extrapolation distribution using a more extensive dataset.
- To assess the consistency of the IPCS framework and APROBA default parameters with newly analyzed toxicological data.
- To identify potential limitations in APROBA's uncertainty quantification for chemical risk assessment.
Main Methods:
- Estimated the subchronic-to-chronic distribution using a larger dataset encompassing histopathological and clinical endpoints, beyond historical body and organ weight data.
- Compared the derived distribution and uncertainty estimates with the default parameters and assumptions within the APROBA software.
- Evaluated dose-response model fit using multiple indicators beyond standard goodness-of-fit statistics.
Main Results:
- The analysis confirmed that key assumptions of the IPCS method and APROBA's default values are generally consistent with the new data.
- However, predictions for dichotomous response data exhibited greater uncertainty than assumed by APROBA, leading to approximately 25% lower reference values in an example case.
- APROBA's default parameters do not fully capture the uncertainty in predicted chronic BMDs, especially when BMDs fall outside the observed dose range or confidence limits are unquantifiable.
Conclusions:
- While the IPCS framework is largely supported, APROBA's default settings may underestimate uncertainty for certain toxicological endpoints.
- More rigorous evaluation of dose-response model fit is crucial for accurate uncertainty quantification in chemical risk assessment.
- The findings highlight the need for careful application and potential refinement of probabilistic methods in setting chemical safety reference values.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Analysis of Population Pharmacokinetic Data